Search This Blog

Friday, May 1, 2026

GoodRx partners with Novo on self-pay access to new oral Ozempic pill starting at $149 per month

 

GoodRx partners with Novo Nordisk to offer self-pay access to new oral Ozempic pill starting at $149 per month

  • Program provides nationwide pharmacy pricing through GoodRx's platform for eligible type 2 diabetes patients.
  • Collaboration covers newly approved oral semaglutide formulation of Ozempic, expanding self-pay options beyond traditional injectable versions.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)